VTRS — Viatris Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Viatris, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-670	-1,269	2,079	54.7	-634
Depreciation
Deferred Taxes
Non-Cash Items	595	909	-1,159	1,203	1,130
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-696	-1,805	-923	-711	-319
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities	1,232	3,017	2,999	2,900	2,303
Capital Expenditures	-681	-509	-443	-475	-347
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	380	392	1,917	-390	2,148
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-301	-118	1,474	-865	1,801
Financing Cash Flow Items	-205	-514	-19.5	-230	206
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-606	-3,012	-3,878	-2,302	-4,330
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	359	-144	556	-269	-258